Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, posted on Twitter:
“I’m really proud of this study. After 20 years since inception, we got the final completion from CIRB today. The trial changed myeloma treatment— a lot of lives saved simply by reducing steroid dose.”
For further details click here.
Source: Vincent Rajkumar/Twitter